Orchestra Biomed Holdings Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
OBIO Nasdaq 3845

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Orchestra Biomed Holdings Inc

Orchestra BioMed Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag - Mar 29th, 2024 10:34 am
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update - Mar 27th, 2024 8:17 pm
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors - Mar 26th, 2024 12:00 pm
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting - Mar 13th, 2024 12:00 pm
Orchestra BioMed to Participate in Upcoming Investor Conferences - Mar 7th, 2024 1:00 pm
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients - Mar 6th, 2024 1:37 pm
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years - Feb 26th, 2024 1:00 pm
Why Orchestra BioMed (OBIO) Might Surprise This Earnings Season - Feb 16th, 2024 2:13 pm
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients - Jan 8th, 2024 12:30 pm
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has caught the attention of hedge funds investors who hold a sizeable 28% stake - Jan 3rd, 2024 2:28 pm
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update - Nov 13th, 2023 9:21 pm
Orchestra BioMed to Present at Upcoming Investor Conferences - Nov 9th, 2023 9:42 pm
Billionaire Marc Lasry’s Top 10 Stock Picks - Oct 30th, 2023 7:52 pm
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients - Sep 19th, 2023 11:30 am
Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors - Sep 6th, 2023 9:00 pm
Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update - Aug 10th, 2023 8:34 pm
Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis - Aug 8th, 2023 12:30 pm
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) stock most popular amongst retail investors who own 36%, while hedge funds hold 28% - Jul 27th, 2023 1:47 pm
Why Shares of Orchestra BioMed Holdings Jumped Wednesday - Jun 28th, 2023 6:16 pm
Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes - Jun 26th, 2023 12:00 pm